B cells in the pathophysiology of autoimmune neurological disorders: a credible therapeutic target

Pharmacology & Therapeutics
M Dalakas

Abstract

There is evidence that B cells are involved in the pathophysiology of many neurological diseases, either in a causative or contributory role, via production of autoantibodies, cytokine secretion, or by acting as antigen-presenting cells leading to T cell activation. Clonal expansion of B cells either in situ or intrathecally and circulating autoantibodies are critical elements in multiple sclerosis (MS), Devic's disease, paraneoplastic central nervous system disorders, stiff-person syndrome, myasthenia gravis, autoimmune demyelinating neuropathies and dermatomyositis. The pathogenic role of B cells and autoantibodies in central and peripheral nervous system disorders, as reviewed here, provides a rationale for investigating whether depletion of B cells with new agents can improve clinical symptomatology and, potentially, restore immune function. Preliminary results from several clinical studies and case reports suggest that B cell depletion may become a viable alternative approach to the treatment of autoimmune neurological disorders.

References

Feb 1, 1991·The Journal of Experimental Medicine·E Roosnek, A Lanzavecchia
Feb 1, 1991·The Journal of Clinical Investigation·D A CarsonT J Kipps
May 31, 1990·The New England Journal of Medicine·M SolimenaP De Camilli
May 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·P RudgeT Poole
Jul 1, 1989·Neuropathology and Applied Neurobiology·D A CompstonB Jasani
Jun 23, 1994·The New England Journal of Medicine·D B Drachman
May 29, 1998·The New England Journal of Medicine·A H Ropper, K C Gorson
Jul 21, 1998·Annals of the New York Academy of Sciences·S Ragheb, R P Lisak
Dec 17, 1998·The New England Journal of Medicine·A H Ropper, M Victor
Aug 14, 1999·Immunology·J C EdwardsV M Abrahams
Nov 18, 2000·European Journal of Biochemistry·A VincentB Lang
Dec 8, 2000·Journal of Neuroimmunology·A H CrossJ Lyons
Jan 10, 2001·Neurology·E CiafaloniD B Sanders
Mar 28, 2001·Clinical Reviews in Allergy & Immunology·A F Carpentier, J Y Delattre
May 17, 2001·Brain : a Journal of Neurology·F GrausJ Y Delattre
Jul 18, 2001·Annals of Neurology·X GuoT M Dawson
Sep 8, 2001·The New England Journal of Medicine·M D Kazatchkine, S V Kaveri
Feb 14, 2002·Seminars in Oncology·Antonio J Grillo-LópezMark Benyunes
Mar 22, 2002·Nature Reviews. Immunology·M J ShlomchikM J Mamula
Mar 29, 2002·American Journal of Hematology·Yvette L KasamonAlessandra F Nascimento
Jun 13, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Daren R Ure, Moses Rodriguez
Jun 22, 2002·Brain : a Journal of Neurology·Claudia F LucchinettiHans Lassmann
Jul 24, 2002·Brain : a Journal of Neurology·Ian K HartKerry R Mills

❮ Previous
Next ❯

Citations

Jan 27, 2010·Neuroscience Bulletin·Sha Huang, Li-Ming Tan
Feb 26, 2010·Annals of Indian Academy of Neurology·Kathleen Hawker
Jan 15, 2014·Journal of Neuroimmunology·George LagoumintzisSocrates J Tzartos
Aug 11, 2007·Current Rheumatology Reports·Marinos C Dalakas
Jun 18, 2011·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Gabriella ZaraM Ermani
Oct 15, 2013·Clinical and Experimental Immunology·P M AbrahamB Soliven
Jul 25, 2014·Rheumatology International·Isabel MoreiraErnestina Santos
Dec 24, 2010·Therapeutic Advances in Neurological Disorders·Mixalis L Kosmidis, Marinos C Dalakas
Sep 20, 2018·Arquivos de neuro-psiquiatria·Min TangFanxia Meng
Jun 17, 2008·Current Opinion in Neurology·Nancy L Monson
Jun 17, 2008·Current Opinion in Neurology·Kathleen Hawker
May 22, 2008·Nature Clinical Practice. Neurology·Sivakumar Sathasivam
Dec 14, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Gloria von GeldernKyra Becker
Jan 21, 2011·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Brandon A Brown, Mina Torabi
Jun 26, 2012·Internal Medicine·Ryotaro IkeguchiKenji Yamamoto
Oct 10, 2007·Journal of Neuro-oncology·Marcello EspositoV Bonavita
Jul 27, 2010·Seminars in Arthritis and Rheumatism·J Michelle Kahlenberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Campylobacteriosis (ASM)

Campylobacteriosis is caused by the bacteria Campylobacter jejuni and is a common cause of gastroenteritis in humans. Discover the latest research on Campylobacteriosis here.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.